All eyes on the inflation data
Marketplace
00:00
China's Biotech Surge: Opportunities and Threats
This chapter explores the rapid growth of China's pharmaceutical industry, particularly in biotech innovations like Zanubrutinib, and the advantages as well as challenges for U.S. drug makers. It emphasizes the necessity for the U.S. to boost investment and reform regulations to maintain its competitiveness in the global biotech landscape.
Transcript
Play full episode
